The new report by Expert Market Research titled, ‘Mexico In-Vitro Diagnostics Market Share, Report and Forecast 2023-2028’, gives an in-depth analysis of the Mexico in-vitro diagnostics market, assessing the market based on its segments like products, technologies, usability, and end-uses.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Mexico In-Vitro Diagnostics Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/mexico-in-vitro-diagnostics-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
• Forecast CAGR (2023-2028): 17.1%
The growing market size can be linked to the rising IVD usage as a result of the increased testing due to the COVID-19 pandemic. The expansion of the market in Mexico is anticipated to be driven by the development of automated IVD systems for labs and hospitals to give quick, precise, and error-free diagnosis.
The market is also expanding as a result of the increasing number of IVD (in vitro diagnostics) products being introduced by major companies. Additionally, the region’s market is anticipated to increase owing to the rising need for genetic testing for personalised healthcare, such as that for diabetes and cancer.
The market in this region is further fuelled by elements including the increased prevalence of chronic diseases, the fast-expanding geriatric population, high healthcare costs, and government financing.
Mexico In-Vitro Diagnostics Industry Definition and Major Segments
Early warning indications and specific risk factors can be found using in-vitro diagnostics, offering up new opportunities for prevention and early intervention. With the use of some in-vitro diagnostics, people with chronic illnesses can self-monitor and manage their own symptoms outside of the constraints of the lab, hospital, or doctor’s office.
By product, the Mexico in-vitro diagnostics market report is segmented into:
Based on technology, the market is classified into:
• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
By usability, the market is classified into:
• Disposable IVD Devices
• Reusable IVD Devices
The end-uses of the Mexico in-vitro diagnostics are:
• Diagnostic Laboratories
• Hospitals and Clinics
Mexico In-Vitro Diagnostics Market Trends
The in-vitro diagnostics market in Mexico is predicted to grow as a result of increased income and living standards in developing nations, which will attract a new, health-conscious population looking for high-quality healthcare. Factors such as the growing population, government insurance, newly insured patients, and modernised healthcare facilities are improving the market growth. Improved ease of use and greater reliability have led to the use of IVDs in home settings also.
Today, users may simply do tests to check their blood glucose levels, identify a urinary tract infection, track their ovulation, and confirm pregnancy. These tests help people maintain their health and provide fast answers to support further medical action. These benefits are anticipated to propel the in-vitro diagnostics market in Mexico.
Key Market Players
The major players in the market are:
- F Hoffmann-La Roche Ltd
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Siemens Healthineer AG
- Abbott Laboratories
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Shira Ellis, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Leave a Reply